You are here: Industry Insights > adult

News List

Adult Weight Gain Likely Explains Link Between Parity, T2DM Risk drugs
August 15, 2019
The seeming association between parity and risk for type 2 diabetes among postmenopausal women is likely explained by adult weight gain, according to a study published online in Obstetrics & Gynecology.
Proportion of CRC Diagnoses Increased in Adults Younger Than 50 drugs
July 23, 2019
From 2004 to 2015, there was an increase in the proportion of persons diagnosed with colorectal cancer (CRC) at an age younger than 50 years in the United States...
45 Percent of U.S. Adults Have Some Doubts About Vaccine Safety drugs
July 09, 2019
Just under half of U.S. adults have some doubts about vaccine safety, according to a survey released by the American Osteopathic Association.
AHA News: 'Surprising' Lack of Progress on Heart Disease in Younger Adults drugs
July 09, 2019
After years of declining rates of coronary artery disease, new research shows the trend is reversing among younger people, especially women.
Most Adult-Use Cannabis Customers Use for Pain, Sleep Relief drugs
July 04, 2019
Most Adult-Use Cannabis Customers Use for Pain, Sleep Relief.
Longevity Benefits for Adults Becoming More Physically Active drugs
July 02, 2019
Longevity Benefits for Adults Becoming More Physically Active.
Less Than 40 Percent of All U.S. Adults Have Ever Had HIV Testing drugs
June 28, 2019
Less Than 40 Percent of All U.S. Adults Have Ever Had HIV Testing.
Fewer New T2DM Cases Seen in Adults on Plant-Based Diet drugs
June 11, 2019
Fewer New T2DM Cases Seen in Adults on Plant-Based Diet.
Rate of Opioid Prescribing High for Teens, Young Adults in ED drugs
May 29, 2019
For adolescents and young adults, the rate of opioid prescribing in emergency departments is high, according to a study published online May 28 in Pediatrics.
FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients drugs
May 15, 2019
FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients.

Previous page 1 2 Next page